MedTrace Logo

Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1)Pneumonia: Multi-centre, Prospective, Randomized Controlled Study

NCT00936013 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2009-11-02

No results posted yet for this study

Summary

The purpose of the study is to determine whether the combination treatment of Chinese medicinal herbs and oseltamivir is more effective than single oseltamivir in treating novel influenza A (H1N1) pneumonia.

Conditions

Interventions

DRUG

oseltamivir

75mg p.o Bid for 5 days

DRUG

oseltamivir and chinese medicinal herbs

oseltamivir: 75mg p.o bid for 5 days chinese medicinal herbs:200ml p.o qid for 5 days

Sponsors & Collaborators

  • Capital Medical University

    lead OTHER

Principal Investigators

  • Chen Wang, Doctor · Beijing Chao Yang Hospital

  • Qingquan Liu, Docter · Beijing Chinese Traditional Medicine University affiliated Dongzhimen Hospital

  • Yu Mao, Doctor · Beijing Ditan Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00936013 on ClinicalTrials.gov